Showing posts with label Syndicate Bank. Show all posts
Showing posts with label Syndicate Bank. Show all posts
30 December 2014
14 November 2014
Business growth to stay slightly ahead of industry - Syndicate Bank :: ICICI Securities, PDF link
CLICK links to Read MORE reports on:
ICICI Securities,
Syndicate Bank
23 June 2013
27 January 2013
Syndicate Bank, Tax write-back boosts profitability…ICICI Sec
Tax write-back boosts profitability…
Profits were higher than our and Street estimate but were mainly driven
by tax write-back of | 174.3 crore (of which MAT credit is | 140.8 crore),
which may continue in Q4FY13. Tax rate for FY14E is expected to remain
low as MAT benefit created in FY13E may be used. At PBT level, results
were dismal with 11.8% YoY de-growth to | 334.2 crore (I-direct estimate:
| 488.3 crore) mainly on account of subdued NII growth. Yield on
advances dipped 16 bps QoQ to 10.7%. Even other income growth was
modest, which included trading income of | 90 crore. We have lowered
our NII estimate from | 6038 crore to | 5542 crore in FY13E and have
accounted for tax write-back that the bank has been taking. Syndicate is
one of the few PSU banks delivering stable asset quality. Hence, investors
can accumulate the stock on correction. At CMP, we recommend HOLD.
Business growth picks up pace, asset quality stable
Credit growth picked up pace with 17.3% YoY growth to | 136648 crore
(up by | 9867 crore QoQ) while deposit growth stood at 14.6% YoY to
| 164075 crore (up by | 8221 crore QoQ). CASA ratio was flat at 32%.
Incrementally, lending grew across sectors except SME. Overseas book
(London branch) increased by | 3346 crore QoQ to | 20301 crore.
Absolute GNPA declined by | 18.6 crore QoQ to | 3160 crore while
slippage trend continued with | 900 crore of fresh slippages in Q3FY13.
Upgradation and recoveries were strong enough to offset these
slippages. Fresh restructuring of | 1000 crore was done to take the total
outstanding restructured assets to ~| 10200 crore (7.6% of total credit).
Moving from consolidation to in line growth…
The bank is expected to move from consolidation phase to growth phase,
which is reflected in improved business growth performance. NIM is
expected to remain above 3%. The consolidation phase of the bank is
auguring well as it is resulting in moderate NPAs now. Its provision
coverage ratio of 83% provides comfort.
Return ratios to remain healthy
Capital infusion from government is expected in FY13E (| 539 crore
factored at | 130). Return ratios are expected to remain decent with RoA
of 0.8% & RoE of 15% in FY14E. Operational performance has improved
with NIM >3% but C/D ratio at ~80% & leverage >20x levels still remain
high. We recommend HOLD rating on the stock and maintain TP of | 140.
CLICK links to Read MORE reports on:
ICICI Securities,
Syndicate Bank
26 January 2013
Syndicate Bank, Lower Provisions and Tax reversal props -Karvy
Lower Provisions and Tax reversal props
Profits
In Q3FY13, Syndicate Bank’s performance came better than our
expectations with PAT growing at 50.4% YoY (up 9.7% QoQ) to Rs5.1 bn,
owing to higher than expected tax write back and lesser than expected
credit costs. NII grew 6% YoY (up 1% QoQ) and NIM declined 4 bps QoQ
at 3.29% due to decline in yield on advances. Asset quality improved
during the quarter owing to lesser slippages. However, balance sheet
growth continues to remain moderate.
Moderate loan Growth: Advances grew at 17.3% YoY (up 6.2% QoQ)
and Deposits grew 14.6% YoY (up 5.3% QoQ). Consequently, C‐D ratio
increased 70 bps to 82.1%. The management has guided 15‐16% credit
growth for FY13.
Asset Quality promising: Syndicate Bank’s asset quality showed further
improvement during the quarter, as net incremental slippages declined
by Rs 186 mn and fresh slippage ratio declined to 2.7% from 3.3% in
H1FY13. Gross NPA ratio declined by 16 bps to 2.31% and net NPA ratio
reduced by 7 bps to 0.85%. The provision coverage ratio is maintained at
83%. The bank restructured loans worth Rs1 bn and the cumulative
restructured loan book stood at Rs 100 bn (7.4% of loan book).
Contraction in NIMs: NIMs declined 4bps sequentially to 3.29% as yield
on advances declined 31 bps sequentially to 9.17%. This was partially
offset by decline in cost of deposits by 30 bps to 6.7%. We expect NIM to
remain around 3.25% in FY13.
Outlook & Valuation
At the CMP the stock is trading at 4.0x and 3.8x FY13E and FY14E EPS, and
at 0.8x and 0.7x FY14E and FY15E P/ABV respectively. We have maintained
our estimates and our price target at Rs175 valuing the stock at 0.9x FY15 and
maintain BUY rating on the stock.
CLICK links to Read MORE reports on:
karvy,
Syndicate Bank
09 September 2012
Syndicate Bank ( TP : ` 145, Buy) :Dolat Capital, top pick
Syndicate Bank (CMP: ` 95, TP : ` 145, Buy)
Syndicate Bank’s management plans to expand credit book faster than the industry, in the range of
18-19% and retail credit book would grow at even faster pace of 22%. Key focus area for credit
growth would be retail, MSME and mid-corporate. We expect credit book to grow 17.4% CAGR in
FY12-14. Faster expansion in retail and MSME books would aid asset yield and margin
The bank plans to increase its CASA share by 100-125 bps to 32% mark. Also, re-pricing of bulk
deposits and CD at lesser rated would aid margin erosion in declining interest rate scenario.
The bank’s management expects 15bps decline in margin to 3.25% from 3.4% in FY12. We factor in
10 bps decline in margin to 2.96% (on yearly average basis) primarily due to decline in interest rates
and re-pricing lag of liabilities
On the back of higher loan growth and alignment of processing charges with peers, fee income is
expected to revive. We expect the bank’s other income to grow by 13% YoY in FY13
As on June’12, the bank’s asset quality improved on sequential basis; further higher PCR provides
comfort for future NPL provisioning. The bank’s management expects to do a substantial recoveries
in FY13
At current price, the stock quotes at 0.65x and 0.56x adjusted book value (ABV) FY13 and FY14
respectively. Based on our price target of ` 145, the stock will trade at 1.0x and 0.9x ABV FY13 and
FY14 respectively
CLICK links to Read MORE reports on:
Dolat Capital,
Syndicate Bank
20 July 2012
Syndicate Bank:: Target Price: ` 152 Buy ::Dolat Capital
Followings are key observations in Syndicate Bank’s financial
performance:
Improvement in liability profile: In FY12, Syndicate Bank recorded
substantial improvement on deposit profile; whole-sale deposits & CDs
proportion declined by 470bps to 21% from 26% a year back and core retail
deposits increased by almost 430bps to 69%
CLICK links to Read MORE reports on:
Dolat Capital,
Syndicate Bank
23 June 2012
Financials - TOP PICKS Syndicate Bank ( TP : ` 149, Buy) Dolat Capital
Financials - TOP PICKS
Syndicate Bank (TP : ` 149, Buy)
We observe a change in bank’s stance with the new senior management. It now intends to grow
faster than industry, in the range of 22-24%. We believe given the cushion of high PCR and lower
slippages, it is achievable subject to overall environment. We expect credit book to grow 19% CAGR
in FY12-14
During FY11 and FY12, due to moderate balance-sheet growth and widespread branch, the bank
has been maintaining high composition of low-cost deposits at ~30% level which aided margin.
Going forward, in FY13, we factor in 14 bps decline in margin to 2.92% (on yearly average basis)
primarily due to decline in interest rates and re-pricing lag of liabilities
On the back of higher loan growth and levying processing charges, fee income growth is expected
to enhance further from current levels. We expect the bank’s other income to grow by 12% YoY in
FY13
As on Mar’12, the bank’s asset quality deteriorated; however, higher PCR gave a buffer to
provisioning in case of increase in bad debts. We expect the bank to do substantial recoveries in
Q1FY13, given the aggressive focus
At current price, the stock quotes at 0.7x and 0.6x adjusted book value (ABV) FY13 and FY14
respectively. Based on our price target of ` 149, the stock will trade at 1.0x and 0.9x ABV FY13 and
FY14 respectively
CLICK links to Read MORE reports on:
Dolat Capital,
Syndicate Bank
16 May 2012
Angel Broking - Syndicate Bank - RU4QFY2012 - Result Updates ::PDF link
Please Share::
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
Syndicate Bank - RU4QFY2012
Visit http://indiaer.blogspot.com/ for complete details �� ��
Syndicate Bank - RU4QFY2012
CLICK links to Read MORE reports on:
Angel Broking,
Syndicate Bank
03 March 2012
Syndicate Bank : TP: ` 120 Accumulate ::Dolat Capital
Please Share::
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
We had a meeting with the bank’s management (Mr. Basant Seth, present
CMD and Mr. M G Sanghvi, Chairman Designate); followings are the key
takeaways of the meeting:
The in-coming CMD (Mr. Sanghvi) appeared confident of expanding bank’s
credit book faster than the banking industry; he expects credit growth in a
range of 22-24% in FY13. There is a change in stance as the present
bank’s management continued with moderate credit book expansion
at 16-17% and the in-coming CMD expects credit expansion higher
than industry pace at 22-24% YoY. The latter believes that there is
significant scope to accelerate retail and MSME loan books.
Credit composition could re-balance in favor of retail credit; its composition
could further increase by 200—300 bps to 23-24% by end-March’13 (from
21% as on end-March’11).
Margin is expected to moderate in FY13 in declining interest rate scenario,
but the in-coming CMD indicated that fresh equity capital and containment
of liabilities cost would lead to marginal drift in margin.
Fee income growth would enhance further on the back of strong loan growth
and levying processing charges diligently across the loan book.
The in-coming CMD said there is a scope of improvement on treasury front
as well. He indicated that in declining interest rate scenario and with serious
efforts in place, the bank could make handsome gains.
On gross NPL front, both the people (the current CMD and in-coming CMD)
indicated that net addition to GNPL would be negligible; GNPL would not
rise hereon by the end-FY13.
The bank’s management expects write-back on tax provision due to writeoff
done in agriculture debt waiver & relief schemes, though this matter
requires further clarity.
Overall, the in-coming CMD sounded quite positive on credit growth (particularly
opportunities in retail credit), fee income growth, treasury gains and past overprovisioning
on employee expenses (below the line) & NPLs.
Visit http://indiaer.blogspot.com/ for complete details �� ��
We had a meeting with the bank’s management (Mr. Basant Seth, present
CMD and Mr. M G Sanghvi, Chairman Designate); followings are the key
takeaways of the meeting:
The in-coming CMD (Mr. Sanghvi) appeared confident of expanding bank’s
credit book faster than the banking industry; he expects credit growth in a
range of 22-24% in FY13. There is a change in stance as the present
bank’s management continued with moderate credit book expansion
at 16-17% and the in-coming CMD expects credit expansion higher
than industry pace at 22-24% YoY. The latter believes that there is
significant scope to accelerate retail and MSME loan books.
Credit composition could re-balance in favor of retail credit; its composition
could further increase by 200—300 bps to 23-24% by end-March’13 (from
21% as on end-March’11).
Margin is expected to moderate in FY13 in declining interest rate scenario,
but the in-coming CMD indicated that fresh equity capital and containment
of liabilities cost would lead to marginal drift in margin.
Fee income growth would enhance further on the back of strong loan growth
and levying processing charges diligently across the loan book.
The in-coming CMD said there is a scope of improvement on treasury front
as well. He indicated that in declining interest rate scenario and with serious
efforts in place, the bank could make handsome gains.
On gross NPL front, both the people (the current CMD and in-coming CMD)
indicated that net addition to GNPL would be negligible; GNPL would not
rise hereon by the end-FY13.
The bank’s management expects write-back on tax provision due to writeoff
done in agriculture debt waiver & relief schemes, though this matter
requires further clarity.
Overall, the in-coming CMD sounded quite positive on credit growth (particularly
opportunities in retail credit), fee income growth, treasury gains and past overprovisioning
on employee expenses (below the line) & NPLs.
CLICK links to Read MORE reports on:
Dolat Capital,
Syndicate Bank
05 February 2012
Query Corner: TCS, SIB, Godrej, IndusInd Bank, Aurobindo Pharma, Syndicate Bank, Lovable Lingerie, Valecha Engineering:: Business Line
Please Share:: Visit http://indiaer.blogspot.com/ for complete details �� ��
Please advise me on the long-term outlook for South Indian Bank. I purchased the share at Rs 18.
T.V.S. Sai
South Indian Bank (Rs 22.9): The long-term outlook for South Indian Bank is positive. The correction from the last quarter of 2010 that devastated many stocks has not affected this stock much.
The stock has displayed resilience by hanging on to the first long-term support at Rs 20. Continued movement in the band between Rs 20 and Rs 30 will retain the positive outlook for the long-term.
The stock then has the potential to break out to Rs 36 or Rs 45 over the long term. Investors can hold the stock as long as it trades above Rs 20. Subsequent supports are at Rs 17 and Rs 14.
Please advise on Godrej Industries and IndusInd Bank.
Priya Vaswani, Sanjay Vaswani
CLICK links to Read MORE reports on:
Aurobindo Pharma,
Business Line,
Godrej Consumer,
IndusInd Bank,
Lovable Lingerie,
SIB,
Syndicate Bank,
TCS,
Valecha Engineering
29 January 2012
Buy Syndicate Bank ; Target : Rs 111 ::ICICI Securities
Please Share::
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
N I M s u r p r i s e s p o s i t i v e l y , l o a n g r o w t h m o d e r a t e s …
Net profit grew 32% YoY and 5% QoQ to | 338 crore ahead of our
estimated | 299 crore boosted by 15.2% YoY NII growth, lower operating
expenses and reduced tax provisions. NIM surprised by expanding 19
bps QoQ to 3.45% from 3.26%. The cost to income ratio declined to
41.8% from 44.8% in Q2FY12 and 47% in Q1FY12. The effective tax rate
further dipped to 10.8% from 15.9% in Q2FY12 but was same as 10.1% in
Q3FY11 mainly due to MAT liability provisions needed for full year. Asset
quality remained relatively stable QoQ due to w/offs and recoveries.
Margins rise 19 bps QoQ…
Yield on funds rose to 9.40% from 9.21% while cost of funds rose to
6.24% from 6.1% leading to NIM expansion to 3.45% from 3.26%
sequentially. Even NII growth of 15.2% YoY and 1% QoQ to | 1325
crore was higher than the estimated | 1300 crore. We believe loans
pending for revised base rate repricing have happened in Q3FY12
resulting in yields surging despite lower 15% YoY credit growth.
We expect NIM to stay above 3% for FY12E supported by credit
growth of 16.3% and deposit growth of 17% for FY12E. Non-interest
income increased marginally by 5.6% YoY to | 244 crore.
GNPA, NNPA decline QoQ, provision coverage at 78.5%…
GNPA declined QoQ to | 2673 crore (2.29%) from | 2721 crore
(2.38%) mainly due to w/offs to the tune of | 110 crore in the
quarter. NNPA also dipped from | 1051 crore (0.86%) to | 992 crore
(0.93%) sequentially. Provisions remained high at | 543 crore vs. our
estimate of | 489 crore. PCR has remained at 78.5%. With risk to
NPAs from power exposure being high, we estimate GNPA at | 2971
crore (2.4%) and NNPA at | 1191 crore (1%) for FY12E.
V a l u a t i o n
The operational performance has improved with NIM >3%, RoA at 0.85%
and RoE at 17.73%. However, the C/D ratio at 81% and leverage (average
assets/average equity) >20x levels still remain high. We maintain our PAT
estimates of | 1612 crore in FY13 with 24% CAGR over FY11-13. The
stock is currently trading at 0.7x FY13E ABV. We are cautiously revising
our target price to | 111 valuing the bank at 0.9x FY13E ABV (1x ABV
earlier) and recommend a BUY rating on it.
Visit http://indiaer.blogspot.com/ for complete details �� ��
N I M s u r p r i s e s p o s i t i v e l y , l o a n g r o w t h m o d e r a t e s …
Net profit grew 32% YoY and 5% QoQ to | 338 crore ahead of our
estimated | 299 crore boosted by 15.2% YoY NII growth, lower operating
expenses and reduced tax provisions. NIM surprised by expanding 19
bps QoQ to 3.45% from 3.26%. The cost to income ratio declined to
41.8% from 44.8% in Q2FY12 and 47% in Q1FY12. The effective tax rate
further dipped to 10.8% from 15.9% in Q2FY12 but was same as 10.1% in
Q3FY11 mainly due to MAT liability provisions needed for full year. Asset
quality remained relatively stable QoQ due to w/offs and recoveries.
Margins rise 19 bps QoQ…
Yield on funds rose to 9.40% from 9.21% while cost of funds rose to
6.24% from 6.1% leading to NIM expansion to 3.45% from 3.26%
sequentially. Even NII growth of 15.2% YoY and 1% QoQ to | 1325
crore was higher than the estimated | 1300 crore. We believe loans
pending for revised base rate repricing have happened in Q3FY12
resulting in yields surging despite lower 15% YoY credit growth.
We expect NIM to stay above 3% for FY12E supported by credit
growth of 16.3% and deposit growth of 17% for FY12E. Non-interest
income increased marginally by 5.6% YoY to | 244 crore.
GNPA, NNPA decline QoQ, provision coverage at 78.5%…
GNPA declined QoQ to | 2673 crore (2.29%) from | 2721 crore
(2.38%) mainly due to w/offs to the tune of | 110 crore in the
quarter. NNPA also dipped from | 1051 crore (0.86%) to | 992 crore
(0.93%) sequentially. Provisions remained high at | 543 crore vs. our
estimate of | 489 crore. PCR has remained at 78.5%. With risk to
NPAs from power exposure being high, we estimate GNPA at | 2971
crore (2.4%) and NNPA at | 1191 crore (1%) for FY12E.
V a l u a t i o n
The operational performance has improved with NIM >3%, RoA at 0.85%
and RoE at 17.73%. However, the C/D ratio at 81% and leverage (average
assets/average equity) >20x levels still remain high. We maintain our PAT
estimates of | 1612 crore in FY13 with 24% CAGR over FY11-13. The
stock is currently trading at 0.7x FY13E ABV. We are cautiously revising
our target price to | 111 valuing the bank at 0.9x FY13E ABV (1x ABV
earlier) and recommend a BUY rating on it.
CLICK links to Read MORE reports on:
ICICI Securities,
Syndicate Bank
30 December 2011
Syndicate Bank- TP: ` 122 Buy:: Dolat
Please Share::
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
The stock of Syndicate Bank corrected sharply by almost 20% in
recent sessions primarily led by concerns over deterioration in
asset quality. In line with these concerns, we have also reduced
our earnings estimates by 6.5% and 16% for FY12 and FY13
respectively. Accordingly we have also reduced our target price
by 18% to Rs 122 at 0.9x ABV FY13.
However, we also believe that the current valuations (stock price)
is reflecting a collapse of profitablity and return ratios, which we
find too pessimistic. Our reverse calculations suggest that the
market is building in RoAA and RoAE of 0.3-0.35% and 8.5-9.5%
respectively. This appears extremely unlikely to us even in the
most pessimistic scenarios. Even in the worst of the times over
the last decade, the bank always reported RoAA of more than
0.6%. We reiterate our BUY rating on the stock based on following
rationale :
Credit book expansion much slower than industry in last couple
of years, hence we see lower risk verse peers on deterioration
of book
Build-up in gross slippages least among peers in recent quarterly
results
Continuous maintainence or step up in NPL coverage even in
most strained times; PCR (including technical write-offs) is
relatively higher at 79% among peers
Deposit rebalancing aiding margin
Management willing to sacrifice balance-sheet size for quality;
foresees bottom-line growth at 25% in FY12. There would be a
top management change in February’12, considering the track
record of incoming CMD (Mr. M. G. Sanghvi, current ED at Bank
of Maharashtra), we believe that the bank’s policy of
conservatism would continue
Expectation of capital infusion in FY13 considering lower Tier I
The stock quotes at historically cheap valuation at 0.6x FY13
ABV with 5.5% dividend yield (on FY12’s dividend)
Credit book expansion much slower than industry in last couple
of years: Syndicate bank prudently reduced its credit expansion pace
from FY10 onwards. The bank also moderated its leveraging of balancesheet
on the back of lesser credit book expansion and equity infusion.
In the current fiscal year, the bank’s management expects credit growth
in proximity of 18% YoY
Visit http://indiaer.blogspot.com/ for complete details �� ��
The stock of Syndicate Bank corrected sharply by almost 20% in
recent sessions primarily led by concerns over deterioration in
asset quality. In line with these concerns, we have also reduced
our earnings estimates by 6.5% and 16% for FY12 and FY13
respectively. Accordingly we have also reduced our target price
by 18% to Rs 122 at 0.9x ABV FY13.
However, we also believe that the current valuations (stock price)
is reflecting a collapse of profitablity and return ratios, which we
find too pessimistic. Our reverse calculations suggest that the
market is building in RoAA and RoAE of 0.3-0.35% and 8.5-9.5%
respectively. This appears extremely unlikely to us even in the
most pessimistic scenarios. Even in the worst of the times over
the last decade, the bank always reported RoAA of more than
0.6%. We reiterate our BUY rating on the stock based on following
rationale :
Credit book expansion much slower than industry in last couple
of years, hence we see lower risk verse peers on deterioration
of book
Build-up in gross slippages least among peers in recent quarterly
results
Continuous maintainence or step up in NPL coverage even in
most strained times; PCR (including technical write-offs) is
relatively higher at 79% among peers
Deposit rebalancing aiding margin
Management willing to sacrifice balance-sheet size for quality;
foresees bottom-line growth at 25% in FY12. There would be a
top management change in February’12, considering the track
record of incoming CMD (Mr. M. G. Sanghvi, current ED at Bank
of Maharashtra), we believe that the bank’s policy of
conservatism would continue
Expectation of capital infusion in FY13 considering lower Tier I
The stock quotes at historically cheap valuation at 0.6x FY13
ABV with 5.5% dividend yield (on FY12’s dividend)
Credit book expansion much slower than industry in last couple
of years: Syndicate bank prudently reduced its credit expansion pace
from FY10 onwards. The bank also moderated its leveraging of balancesheet
on the back of lesser credit book expansion and equity infusion.
In the current fiscal year, the bank’s management expects credit growth
in proximity of 18% YoY
CLICK links to Read MORE reports on:
Dolat Capital,
Syndicate Bank
25 December 2011
Sizzling Stocks: Shriram Transport Finance, Syndicate Bank :: Business Line
Please Share::
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
Shriram Transport Finance (Rs 445)
Visit http://indiaer.blogspot.com/ for complete details �� ��
Shriram Transport Finance (Rs 445)
Shriram Transport Finance nosedived 13.7 per cent, breaking through its key short-term support at around Rs 500, in the previous week. This decline has reinforced the intermediate-term downtrend that has been in place since its November 2010 peak of Rs 899. Medium-term trend is also down for the stock from September 2011 high of Rs 707. There can be a minor corrective up move to Rs 460 or to Rs 500, as the stock has fallen steeply recently. However, the possibility of declining further and testing the stock's long-term support at Rs 400 is on the cards. Next long-term supports are at Rs 350 and Rs 300. Significant medium-term resistances are at Rs 570 and Rs 610.
Syndicate Bank (Rs 74.10)
The stock plummeted 16.7 per cent in the last week, penetrating key long-term supports at around Rs 90 and then at Rs 80. The stock has reached oversold levels, as its daily indicators and oscillators are featuring in the oversold territory. Moreover, the stock has breached the lower boundary of the Bollinger bands signalling oversold levels. Therefore, we don't rule out a minor corrective rally to Rs 80 and then to Rs 85 in the short-term. Next important resistances are at Rs 90 and Rs 97. Failure to surpass Rs 80 will pull the stock lower to Rs 71. Long-term trend is down for the stock ever since its life-time high of Rs 164 was marked in November 2010. Strong breach of Rs 71 will pull the stock down to Rs 65 in the medium term.
CLICK links to Read MORE reports on:
Business Line,
Shriram Transport Finance,
Syndicate Bank
24 December 2011
Syndicate Bank :: Stocks for 2012 : Hedge Research
Please Share::
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
Syndicate Bank Limited
Investment Profile: Aggressive Horizon: 1-1.5 Yrs
Business Summary Syndicate Bank Limited (SBL) is a Karnataka based public sector bank that has a strong presence in the rural and semi urban locations of the country. SBL seeks to position itself as “A Small Man‟s Big Bank”.
Investment Rationale SBL has quite a strong branch network of 2494 branches but what needs to be emphasized is that a majority of these branches are in the Semi-urban and rural territories of the country-territories where new generation banks lack a presence and where competition is less prevalent. SBL is well positioned to develop a loyal customer base. At the end of FY11, SBL‟s branch network included 80 rural branches and 2494 semi-urban branches. The SBL stock is quite remunerative from a dividend perspective with a dividend yield of around 3.5%. We have employed a weighted average valuation approach of determining our share target price of Rs.128. We have assigned 40% weights to our DCF and PBV targets with a 20% weight for the PE target. Our buying level of
see full list at
Visit http://indiaer.blogspot.com/ for complete details �� ��
Syndicate Bank Limited
Investment Profile: Aggressive Horizon: 1-1.5 Yrs
Business Summary Syndicate Bank Limited (SBL) is a Karnataka based public sector bank that has a strong presence in the rural and semi urban locations of the country. SBL seeks to position itself as “A Small Man‟s Big Bank”.
Investment Rationale SBL has quite a strong branch network of 2494 branches but what needs to be emphasized is that a majority of these branches are in the Semi-urban and rural territories of the country-territories where new generation banks lack a presence and where competition is less prevalent. SBL is well positioned to develop a loyal customer base. At the end of FY11, SBL‟s branch network included 80 rural branches and 2494 semi-urban branches. The SBL stock is quite remunerative from a dividend perspective with a dividend yield of around 3.5%. We have employed a weighted average valuation approach of determining our share target price of Rs.128. We have assigned 40% weights to our DCF and PBV targets with a 20% weight for the PE target. Our buying level of
see full list at
Stocks for 2012 : Hedge Research
CLICK links to Read MORE reports on:
2012 ideas,
Syndicate Bank
02 November 2011
Syndicate Bank, :: 2QFY2012 Result Update -Angel Broking,
Please Share::
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
For 2QFY2012, Syndicate Bank reported a 36.2% yoy growth in its net profit to
`323cr well ahead of our as well as street estimates. However, the earnings
growth was partly driven by a lower effective tax rate than expected, on the PBT
front the numbers were 7.5% ahead of our estimates. NIM expansion was healthy;
however slippages rose sharply (due to completion of switch-over to the systembased
NPA recognition platform) which were offset by aggressive write-offs and
upgrades. We maintain a Buy recommendation on the stock.
NIM rebounds; slippages to decline going forward: The bank’s advances grew by
3.3% qoq (up 18.9% yoy), while deposits accretion picked up pace to rise by 6.2%
qoq (up by 21.5% yoy). CASA deposits growth was muted at 6.4% yoy, leading to
a 433bp yoy dip in CASA ratio. The bank’s reported NIMs for the quarter
rebounded by 28bp qoq to 3.4% on the back of a 71bp qoq expansion in loan
yields as compared to a 33bp rise in cost of deposits. On the asset quality front,
the sharp rise in slippages was countered by aggressive write-offs. The annualized
slippage ratio rose to 3.6% from 1.3% in 1QFY2012, as the bank completed the
switch-over to system-based NPA recognition platform. However aggressive
write-offs and business growth resulted in sequentially flat gross and net NPA
ratios at 2.4% and 0.9%, respectively. The provision coverage ratio including
technical write offs remained healthy at 78.5%.
Outlook and valuation: At the CMP, the stock is trading at attractive valuations of
0.7x FY2013E ABV compared to its five-year range of 0.7x–1.3x one-year forward
ABV with a median of 0.9x. Keeping in mind the bank’s stable asset quality,
moderate growth strategy over the past couple of years and moderate NIM, the
valuation appears cheap relative to its peers. We value the stock at 0.85x
FY2013E ABV and maintain a Buy recommendation with a target price of `127.
Visit http://indiaer.blogspot.com/ for complete details �� ��
For 2QFY2012, Syndicate Bank reported a 36.2% yoy growth in its net profit to
`323cr well ahead of our as well as street estimates. However, the earnings
growth was partly driven by a lower effective tax rate than expected, on the PBT
front the numbers were 7.5% ahead of our estimates. NIM expansion was healthy;
however slippages rose sharply (due to completion of switch-over to the systembased
NPA recognition platform) which were offset by aggressive write-offs and
upgrades. We maintain a Buy recommendation on the stock.
NIM rebounds; slippages to decline going forward: The bank’s advances grew by
3.3% qoq (up 18.9% yoy), while deposits accretion picked up pace to rise by 6.2%
qoq (up by 21.5% yoy). CASA deposits growth was muted at 6.4% yoy, leading to
a 433bp yoy dip in CASA ratio. The bank’s reported NIMs for the quarter
rebounded by 28bp qoq to 3.4% on the back of a 71bp qoq expansion in loan
yields as compared to a 33bp rise in cost of deposits. On the asset quality front,
the sharp rise in slippages was countered by aggressive write-offs. The annualized
slippage ratio rose to 3.6% from 1.3% in 1QFY2012, as the bank completed the
switch-over to system-based NPA recognition platform. However aggressive
write-offs and business growth resulted in sequentially flat gross and net NPA
ratios at 2.4% and 0.9%, respectively. The provision coverage ratio including
technical write offs remained healthy at 78.5%.
Outlook and valuation: At the CMP, the stock is trading at attractive valuations of
0.7x FY2013E ABV compared to its five-year range of 0.7x–1.3x one-year forward
ABV with a median of 0.9x. Keeping in mind the bank’s stable asset quality,
moderate growth strategy over the past couple of years and moderate NIM, the
valuation appears cheap relative to its peers. We value the stock at 0.85x
FY2013E ABV and maintain a Buy recommendation with a target price of `127.
CLICK links to Read MORE reports on:
Angel Broking,
Syndicate Bank
10 August 2011
Buy Syndicate Bank; Target : Rs 137:: ICICI Securities
Please Share::
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
N I I i n l i n e , P A T a h e a d o f e x p e c t a t i o n s …
Syndicate Bank witnessed 15% YoY NII growth (4.4% QoQ de-growth) to
| 1111 crore in line with estimates. NIM improved 7 bps YoY (5 bps QoQ)
from 3.09% to 3.16% on better liability management. The yield on
advances stood at 10.2% (9.1% in Q1FY11) with spread being maintained
YoY at 3.8%. We expect NIM at 3% for FY12E supported by credit growth
of 16.3% and deposit growth of 17% for FY12E. Cost to income ratio
declined 3% YoY to 47% as staff cost was | 454 crore, lower than our
estimate of | 505 crore. On the back of lower operating expense and
lower effective tax rate at 17.6%, PAT grew 29% YoY (our estimate:
10.4% YoY) from | 265 crore to | 343 crore in Q1FY12. We maintain our
PAT estimates of | 1612 crore in FY13 with CAGR of 24% over FY11-13.
Core business driving net profit growth
NII increased from | 963 crore in Q1FY11 to | 1111 crore in Q1FY12
contributing | 148 crore to increase in net profit of | 78 crore YoY.
This shows the core business is doing well. Non-interest income
contributed | 75 crore YoY. This contribution to profit was offset by
| 67 crore increase in operating expenses and | 78 crore increase in
provisions. We expect NII growth of 17% CAGR over FY11-13E.
Asset quality to be monitored in near term
The bank is yet to transfer its loan book of below | 25 lakh to
system based recognition of NPA. We expect further slippages from
these accounts and estimate GNPA at | 2971 crore (currently at |
2637 crore) while NNPA is at | 1191 crore (now at | 1018 crore) for
FY12. Restructured assets were | 4534 crore, up | 6 crore QoQ as
slippages and recoveries offset each other. The bank has diversified
exposure to all sectors where its exposure to the power sector
stands at | 9000 crore (~8% of loan book) against industry at 7%.
The bank is confident of maintaining its asset quality while shifting
to 100% system based recognition and PCR of 78% looks sound.
V a l u a t i o n
The bank is not growing at the cost of spread, which helped them to
maintain NIM above 3% for the last five quarters. Strong core business
performance, diversified exposure and cheap valuations make Syndicate
Bank a good long-term bet. We maintain our target price of | 137 valuing
the bank at 1.1x FY13E ABV and recommend BUY rating
Visit http://indiaer.blogspot.com/ for complete details �� ��
N I I i n l i n e , P A T a h e a d o f e x p e c t a t i o n s …
Syndicate Bank witnessed 15% YoY NII growth (4.4% QoQ de-growth) to
| 1111 crore in line with estimates. NIM improved 7 bps YoY (5 bps QoQ)
from 3.09% to 3.16% on better liability management. The yield on
advances stood at 10.2% (9.1% in Q1FY11) with spread being maintained
YoY at 3.8%. We expect NIM at 3% for FY12E supported by credit growth
of 16.3% and deposit growth of 17% for FY12E. Cost to income ratio
declined 3% YoY to 47% as staff cost was | 454 crore, lower than our
estimate of | 505 crore. On the back of lower operating expense and
lower effective tax rate at 17.6%, PAT grew 29% YoY (our estimate:
10.4% YoY) from | 265 crore to | 343 crore in Q1FY12. We maintain our
PAT estimates of | 1612 crore in FY13 with CAGR of 24% over FY11-13.
Core business driving net profit growth
NII increased from | 963 crore in Q1FY11 to | 1111 crore in Q1FY12
contributing | 148 crore to increase in net profit of | 78 crore YoY.
This shows the core business is doing well. Non-interest income
contributed | 75 crore YoY. This contribution to profit was offset by
| 67 crore increase in operating expenses and | 78 crore increase in
provisions. We expect NII growth of 17% CAGR over FY11-13E.
Asset quality to be monitored in near term
The bank is yet to transfer its loan book of below | 25 lakh to
system based recognition of NPA. We expect further slippages from
these accounts and estimate GNPA at | 2971 crore (currently at |
2637 crore) while NNPA is at | 1191 crore (now at | 1018 crore) for
FY12. Restructured assets were | 4534 crore, up | 6 crore QoQ as
slippages and recoveries offset each other. The bank has diversified
exposure to all sectors where its exposure to the power sector
stands at | 9000 crore (~8% of loan book) against industry at 7%.
The bank is confident of maintaining its asset quality while shifting
to 100% system based recognition and PCR of 78% looks sound.
V a l u a t i o n
The bank is not growing at the cost of spread, which helped them to
maintain NIM above 3% for the last five quarters. Strong core business
performance, diversified exposure and cheap valuations make Syndicate
Bank a good long-term bet. We maintain our target price of | 137 valuing
the bank at 1.1x FY13E ABV and recommend BUY rating
CLICK links to Read MORE reports on:
ICICI Securities,
Syndicate Bank
23 March 2011
Buy Syndicate Bank; Target : Rs137 :ICICI Securities
Please Share::
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
C a p i t a l i n f u s i o n : b o o k v a l u e a c c r e t i v e …
Syndicate Bank has announced GoI’s capital infusion of | 633 crore to
boost the Tier I capital of the bank. This would be by way of preferential
allotment of equity. Going forward, we estimate 16% CAGR in balance
sheet to guide 26% CAGR in PAT over FY11-13E to | 1645 crore.
Capital infusion to support business growth, more capital required
In our industry report, “Further sell-offs, an opportunity to accumulate”,
we had outlined a scenario that banks like Syndicate Bank will attract
capital infusion. On similar lines, on March 19, the bank did announce
allotment of 5.13 crore shares to GoI at | 123 (| 113 towards share
premium). This will support our thesis of 17% CAGR in business mix over
FY11-13E to | 332543 crore. The bank would require further capital due to
higher leverage cited by us, since the growth is getting stretched in
FY13E. On account of higher GoI holding (66% prior to this dilution), we
do not rule out fund raising from secondary markets by way of FPO.
Incorporating FY13E
We expect slippages from restructured assets (overhang on asset quality)
to peak out in FY12E. We expect GNPA@ 2.1%, NNPA@0.9%, NIM @3%
and better operating matrix to bode well for the bank.
V a l u a t i o n
The bank has recently adopted the policy of quality and profitable growth,
which is working well for the bank. The bank has stopped growing
business at negative spreads. This has resulted in an improvement in the
NIM and RoE. We were concerned over the asset quality of the bank since
we expected higher slippage from their restructured portfolio. However,
so far the bank has reported slippages of 8% (one of the lowest among
PSB). We would be closely watching the movement in asset quality in the
coming quarters and have built in higher credit cost to that extent. We
have valued the bank at 1.2x FY13E ABV (applying single stage Gordon
growth valuation model) and recommend BUY on the stock.
Visit http://indiaer.blogspot.com/ for complete details �� ��
C a p i t a l i n f u s i o n : b o o k v a l u e a c c r e t i v e …
Syndicate Bank has announced GoI’s capital infusion of | 633 crore to
boost the Tier I capital of the bank. This would be by way of preferential
allotment of equity. Going forward, we estimate 16% CAGR in balance
sheet to guide 26% CAGR in PAT over FY11-13E to | 1645 crore.
Capital infusion to support business growth, more capital required
In our industry report, “Further sell-offs, an opportunity to accumulate”,
we had outlined a scenario that banks like Syndicate Bank will attract
capital infusion. On similar lines, on March 19, the bank did announce
allotment of 5.13 crore shares to GoI at | 123 (| 113 towards share
premium). This will support our thesis of 17% CAGR in business mix over
FY11-13E to | 332543 crore. The bank would require further capital due to
higher leverage cited by us, since the growth is getting stretched in
FY13E. On account of higher GoI holding (66% prior to this dilution), we
do not rule out fund raising from secondary markets by way of FPO.
Incorporating FY13E
We expect slippages from restructured assets (overhang on asset quality)
to peak out in FY12E. We expect GNPA@ 2.1%, NNPA@0.9%, NIM @3%
and better operating matrix to bode well for the bank.
V a l u a t i o n
The bank has recently adopted the policy of quality and profitable growth,
which is working well for the bank. The bank has stopped growing
business at negative spreads. This has resulted in an improvement in the
NIM and RoE. We were concerned over the asset quality of the bank since
we expected higher slippage from their restructured portfolio. However,
so far the bank has reported slippages of 8% (one of the lowest among
PSB). We would be closely watching the movement in asset quality in the
coming quarters and have built in higher credit cost to that extent. We
have valued the bank at 1.2x FY13E ABV (applying single stage Gordon
growth valuation model) and recommend BUY on the stock.
CLICK links to Read MORE reports on:
ICICI Securities,
Syndicate Bank
05 February 2011
Buy Syndicate Bank ; Target Rs 125: ICICI Securities
Please Share::
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
Syndicate Bank -So far, so good…
Syndicate Bank (SBL) reported a healthy growth of 18% YoY in
business mix as deposits grew 15% to | 124603 crore and advances
by 22% to | 101307 crore. CD ratio is stretched at 81%. NII growth
was healthy backed by better liability management. Non interest
income growth was sluggish, down 4% QoQ, 8% YoY to | 214 crore,
lower than estimates. Provisions were high at | 427 crore, resulting in
PAT of | 256 crore little ahead of our estimate of | 234 crore. Going
ahead, we expect 16% CAGR in balance sheet and 17% in business
mix to support PAT CAGR of 29% over FY10-12E to | 13544 crore.
Visit http://indiaer.blogspot.com/ for complete details �� ��
Syndicate Bank -So far, so good…
Syndicate Bank (SBL) reported a healthy growth of 18% YoY in
business mix as deposits grew 15% to | 124603 crore and advances
by 22% to | 101307 crore. CD ratio is stretched at 81%. NII growth
was healthy backed by better liability management. Non interest
income growth was sluggish, down 4% QoQ, 8% YoY to | 214 crore,
lower than estimates. Provisions were high at | 427 crore, resulting in
PAT of | 256 crore little ahead of our estimate of | 234 crore. Going
ahead, we expect 16% CAGR in balance sheet and 17% in business
mix to support PAT CAGR of 29% over FY10-12E to | 13544 crore.
CLICK links to Read MORE reports on:
ICICI Securities,
Syndicate Bank
03 February 2011
SYNDICATE BANK Stable margins; business momentum picks up: Edelweiss
Please Share::
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
Syndicate Bank reported NII of INR 11.5 bn (up 60.2% Y-o-Y, 3.8% Q-o-Q) in
Q3FY11, ahead of our estimate (INR 11.17 bn), aided by stable margins (to 3.58%)
and strong loan book growth (6% Q-o-Q). On account of weak traction in exchange
income (down 26% Q-o-Q), core fee income declined 9% sequentially. Slippages
came in a tad higher at INR 4.0 bn (1.7%) against INR 3.15 bn run rate during the
previous two quarters. Provision coverage improved sequentially by 1 percentage
point to 74%. Bucking the industry trend, deposit growth (7% Q-o-Q) came in
higher than advances growth; hence, the bank’s CD ratio declined sequentially by 2
percentage points to 80%. CASA ratio remained stable at 34%. On account of lower–
than-expected fee income and higher loan loss provisioning, PAT came in at INR 2.56
bn (up 8% Q-o-Q, 25% Y-o-Y), below our estimate (INR 2.8 bn).
Visit http://indiaer.blogspot.com/ for complete details �� ��
Syndicate Bank reported NII of INR 11.5 bn (up 60.2% Y-o-Y, 3.8% Q-o-Q) in
Q3FY11, ahead of our estimate (INR 11.17 bn), aided by stable margins (to 3.58%)
and strong loan book growth (6% Q-o-Q). On account of weak traction in exchange
income (down 26% Q-o-Q), core fee income declined 9% sequentially. Slippages
came in a tad higher at INR 4.0 bn (1.7%) against INR 3.15 bn run rate during the
previous two quarters. Provision coverage improved sequentially by 1 percentage
point to 74%. Bucking the industry trend, deposit growth (7% Q-o-Q) came in
higher than advances growth; hence, the bank’s CD ratio declined sequentially by 2
percentage points to 80%. CASA ratio remained stable at 34%. On account of lower–
than-expected fee income and higher loan loss provisioning, PAT came in at INR 2.56
bn (up 8% Q-o-Q, 25% Y-o-Y), below our estimate (INR 2.8 bn).
CLICK links to Read MORE reports on:
Edelweiss,
Syndicate Bank
Subscribe to:
Posts (Atom)
